NGVT vs PATH · rev $1.41B vs P/E 19, rev $1.61B
Ingevity Corp (NGVT) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Ingevity Corp (NGVT) is a specialty chemicals company listed on NYSE.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported NGVT revenue for 2024-12-31 was $1.41B. Net income was -$430.3M. Revenue was down 16.9% from 2023-12-31 to 2024-12-31. NGVT currently screens at market cap $2.52B.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
NGVT currently screens at market cap $2.52B. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the NGVT and PATH stock pages for the full models.
Not investment advice.